Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Malignant Melanoma of Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07820033
What this trial is testing

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial

Who this might be right for
Advanced CancerStage IV Solid Tumor CancerStage IV Sarcoma of Bone+3 more
University Health Network, Toronto 46
Testing effectiveness (Phase 2)Study completedNCT00238329
What this trial is testing

PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Barbara Ann Karmanos Cancer Institute 32
Testing effectiveness (Phase 2)Study completedNCT00525031
What this trial is testing

Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 55
Large-scale testing (Phase 3)Ended earlyNCT00540969
What this trial is testing

Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer+2 more
Alliance for Clinical Trials in Oncology 3
Testing effectiveness (Phase 2)Study completedNCT00928902
What this trial is testing

Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma

Who this might be right for
Melanoma
University of Virginia 41
Large-scale testing (Phase 3)Ended earlyNCT04588246
What this trial is testing

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more
NRG Oncology 19
Early research (Phase 1)Ended earlyNCT02200562
What this trial is testing

Ipilimumab and Dabrafenib in the 1st Line Tx of Unresectable Stage III/IV Melanoma

Who this might be right for
Stage III or IV Melanoma
University of Utah 6
Not applicableEnded earlyNCT02236546
What this trial is testing

FDG-PET in Advanced Melanoma

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more
Vanderbilt-Ingram Cancer Center 3
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Early research (Phase 1)Study completedNCT02141542
What this trial is testing

Phase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Metastatic Melanoma
F. Stephen Hodi, MD 15
Very early researchNot Yet RecruitingNCT06212388
What this trial is testing

Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma

Who this might be right for
Melanoma
Xijing Hospital 10
Early research (Phase 1)Ended earlyNCT01519323
What this trial is testing

BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 6
Testing effectiveness (Phase 2)Study completedNCT02304458
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

Who this might be right for
Metastatic MelanomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 140
Early research (Phase 1)Study completedNCT00025181
What this trial is testing

Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 19
Large-scale testing (Phase 3)Active Not RecruitingNCT05933577
What this trial is testing

A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 1,089
Testing effectiveness (Phase 2)Study completedNCT00466687
What this trial is testing

Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma
Vanderbilt-Ingram Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT02392871
What this trial is testing

Radiotherapy & Combi in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Melanoma and Skin Cancer Trials Limited 10
Early research (Phase 1)Ended earlyNCT01940809
What this trial is testing

Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
BRAF V600E Mutation PresentBRAF V600K Mutation PresentMetastatic Melanoma+5 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07492121
What this trial is testing

Screening for Brain Metastases

Who this might be right for
Lung Cancer Stage IVMelanoma Stage IVBreast Cancer Metastatic
University of Zurich 180
Testing effectiveness (Phase 2)Study completedNCT01961115
What this trial is testing

Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Mucosal MelanomaRecurrent MelanomaRecurrent Uveal Melanoma+8 more
Fred Hutchinson Cancer Center 11
Next Page